Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Cytokinetics (CYTK)
NASDAQ:CYTK
CYTK Analyst Ratings
Strong Buy
14 Buy
1 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
CYTK Stock 12 Month Forecast
Average Price Target
$80.23
▲(56.94% Upside)
| Highest Price Target$120.00 | Average Price Target$80.23 | Lowest Price Target$62.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Jefferies
Reiterated
02/18/25
Stifel Nicolaus
Reiterated
02/18/25
Morgan Stanley
Upgraded
02/13/25
JMP Securities
Reiterated
02/07/25
Evercore ISI
Initiated
02/06/25
Truist Financial
Reiterated
02/06/25
Needham
Reiterated
02/06/25
Leerink Partners
Reiterated
02/06/25
Mizuho Securities
Reiterated
02/06/25
B.Riley Financial
$92→$88
Buy
72.14%
Upside
Reiterated
02/06/25
Cytokinetics' Aficamten: Promising Phase III Trials and Market Expansion Justify Buy RatingWe reiterate our bullish view on Buy-rated CYTK... further upside to our $88 PT (lowered from $92).
H.C. Wainwright
$120
Buy
134.74%
Upside
Reiterated
01/22/25
Cytokinetics' Innovative CK-586 Advances Bolster Buy Rating Amid HFpEF Promise
Bank of America Securities
$62
Hold
21.28%
Upside
Reiterated
01/06/25
Bank of America Securities Sticks to Their Hold Rating for Cytokinetics (CYTK)
RBC Capital
$80→$82
Buy
60.41%
Upside
Reiterated
12/18/24
Cytokinetics (CYTK) PT Raised to $82 at RBC Capital Following Bayer PartnershipRBC Capital analyst Leonid Timashev raised the price target on Cytokinetics (NASDAQ: CYTK) to $82.00 (from $80.00) while maintaining a Outperform rating.
J.P. Morgan
―
Buy
―
Reiterated
12/02/24
Cytokinetics Gains Momentum: Aficamten's Regulatory Progress and Market Potential Propel 'Buy' Rating
Best Analysts Covering Cytokinetics
Which Analyst Should I Follow If I Want to Buy CYTK and Sell After:
1 Month
xxx
Success Rate
26/48 ratings generated profit
Average Return
+4.80%
reiterated a xxx
rating 16 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 54.17% of your transactions generating a profit, with an average return of +4.80% per trade.
3 Months
xxx
Success Rate
10/15 ratings generated profit
Average Return
+22.71%
upgraded a xxx
rating 9 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 66.67% of your transactions generating a profit, with an average return of +22.71% per trade.
1 Year
Success Rate
13/15 ratings generated profit
Average Return
+93.67%
upgraded a buy rating 9 days ago
Copying Jeffrey Hung's trades and holding each position for 1 Year would result in 86.67% of your transactions generating a profit, with an average return of +93.67% per trade.
2 Years
xxx
Success Rate
14/15 ratings generated profit
Average Return
+127.19%
upgraded a xxx
rating 9 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 93.33% of your transactions generating a profit, with an average return of +127.19% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
CYTK Analyst Recommendation Trends
Rating
Oct 24
Nov 24
Dec 24
Jan 25
Feb 25
Strong Buy
21
21
18
18
20
Buy
17
21
18
14
8
Hold
11
12
7
7
3
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
49
54
43
39
31
Each month's total comprises the sum of three months' worth of ratings.
CYTK Financial Forecast
CYTK Stock Forecast FAQ
What is CYTK’s average 12-month price target, according to analysts?
Based on analyst ratings, Cytokinetics’s 12-month average price target is $80.23.
What is CYTK’s upside potential, based on the analysts’ average price target?
Cytokinetics has 56.94% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is CYTK a Buy, Sell or Hold?
Cytokinetics has a consensus rating of Strong Buy which is based on 14 buy ratings, 1 hold ratings and 0 sell ratings.
What is Cytokinetics’s price target?
The average price target for Cytokinetics is $80.23. This is based on 15 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $120.00 ,the lowest forecast is $62.00. The average price target represents 56.94% Increase from the current price of $51.12.
The highest analyst price target is $120.00 ,the lowest forecast is $62.00. The average price target represents 56.94% Increase from the current price of $51.12.
What do analysts say about Cytokinetics?
Cytokinetics’s analyst rating consensus is a Strong Buy. This is based on the ratings of 15 Wall Streets Analysts.
How can I buy shares of CYTK?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.